Sample of synthetic peptide vaccine SPf66

Made:
1992

Sample of synthetic peptide vaccine SPf66, developed by Dr Patarroyo and collaborators as a synthetic vaccine for malaria, Bogota, Colombia, with placebo, as used in the Phase III randomised, double-blind, placebo controlled trial at La Tola, Colombia, 1992. (The Lancet, 20 March 1993)

Details

Category:
Public Health & Hygiene
Object Number:
1994-446
type:
vaccines and immunisation (malaria)
credit:
Patarroyo, M.E.